GlaxoSmithKline plant to start exporting to 43 new markets

This is to be achieved chiefly thanks to launching the production of four new drugs. "In 2005, foreign sales topped zł.500 million. In four years, this is going to be worth one billion. We have won an internal tender for the production of four new pharmaceuticals for the needs of the whole concern. The drugs will be exported from Poland to 43 new markets (Western Europe, Africa, Asia). Starting this year, we will be systematically launching their production," said the financial director of the Poznań plant, Piotr Pawlak. Thanks to the new contract, the company will export to 63 foreign markets, which is a growth of 65%. This year, the sales of the domestic division of GSK are to increase by zł.200 million and reach zł.1.9 billion. Up to now, GSK, which controls around 8% of the domestic pharmaceutical market, has invested a total of $400 million in the Polish market. (Puls Biznesu, pp.10) A.K.